Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
Prescription To Otc Switch Consumer Advertising, Marketing & Sales

US FDA Has Model Drug Facts Labels For OTC Naloxone, Needs Switch Proposals

  • News

Executive Summary

Development of the model DFLs was a first for agency. The project was "part of our broader commitment to addressing the opioid crisis" and should help sponsors with potential naloxone OTC switch NDAs, says Commissioner Scott Gottlieb.

Table

View full table

Advertisement

Related Content

HBW Insight
FDA Stretching Available Funds, Skeleton Workforce In Gov Shutdown Week Three
Pink Sheet
Shutdown Week Three: Sponsors With Upcoming User Fee Dates Should Start Sweating
HBW Insight
OTC Switch For Naloxone Finding Interest Among Sponsors
Pink Sheet
OTC Switch For Naloxone Finding Interest Among Sponsors
HBW Insight
Naloxone OTC Switch Application On Horizon Thanks To $3.4M Funding From Purdue
Pink Sheet
Naloxone OTC Switch Application On Horizon Thanks To $3.4M Funding From Purdue
HBW Insight
Nonprofit Pharma Targets Making Naloxone Available OTC, Trimming Price
Pink Sheet
Nonprofit Pharma Targets Making Naloxone Available OTC, Trimming Price
HBW Insight
FDA's OTC Naloxone Study Is A Starting Point For Other Switches, Not A Roadmap
Pink Sheet
FDA's OTC Naloxone Study Is A Starting Point For Other Switches, Not A Roadmap

Topics

Related Companies

Advertisement
Tags:
Prescription To Otc Switch Consumer Advertising, Marketing & Sales
UsernamePublicRestriction

Register

PS124595

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By